Suchergebnisse

EOG Resources, Inc. EOG used its second-quarter 2026 earnings call to emphasize that record cash generation reflected more than stronger oil prices. Management focused on execution, spending

McKesson Corporation MCK used its first-quarter fiscal 2027 call to frame the year around stronger North American Pharmaceutical execution, specialty demand and disciplined reinvestment. Management

Kulicke and Soffa Industries, Inc. KLIC used its fiscal second-quarter 2026 earnings call to frame a faster demand recovery and a larger commitment to advanced packaging capacity.

Earnings of $1.20

Novo Nordisk A/S NVO used its second-quarter 2026 earnings call to emphasize stronger GLP-1 momentum, led by Wegovy pill, while highlighting pricing pressure, patent expirations and competition.

The

BorgWarner Inc. BWA used its Q2 2026 earnings call to stress margin expansion, higher full-year earnings guidance and faster investment in data-center power products. Management said cost discipline

Phillips 66 PSX used its second-quarter 2026 earnings call to argue that tight product supply and stronger execution can sustain refining profitability.

Adjusted earnings of $9.41 per share beat the

The Kraft Heinz Company KHC used its Q2 2026 earnings call to increase brand investment after early improvements in consumption and market share. Management framed the added spending as preparation

Delek US Holdings, Inc. DK used its second-quarter 2026 call to emphasize stronger cash generation, improved refinery reliability and a disciplined response to volatile crude and product markets.

McDonald's Corporation MCD used its Q2 2026 earnings call to acknowledge that U.S. execution, not strategy, held back performance. Management outlined corrective actions around value, digital

CVS Health Corporation CVS used its Q2 2026 earnings call to pair stronger 2026 expectations with an early warning about pharmacy-services pressure next year. Management emphasized Aetna’s recovery

For investors seeking momentum, Calamos S&P 500 Structured Alt Protection ETF- March CPSR is probably on the radar now. The fund just hit a 52-week high and is up 6.4% from its 52-week low price of

Veralto Corporation VLTO shares have gained 13.2% in the past three months as earnings expectations improved and second-quarter operating results strengthened. The advance puts the focus on whether

Block, Inc. XYZ raised its 2026 outlook after second-quarter gross profit grew 25% and the adjusted operating income margin reached a record 27%. Management focused on stronger Square trends, deeper

Ternium S.A. TX used its second-quarter earnings call to signal that improving steel conditions in Mexico and firmer pricing should carry into the third quarter. Management expects adjusted EBITDA

Hecla Mining Company HL used its second-quarter 2026 earnings call to emphasize a stronger balance sheet and organic growth pipeline, even as the timeline for materially higher Keno Hill production

Alto Ingredients, Inc. ALTO delivered a sharp improvement in second-quarter 2026 adjusted EBITDA, providing further evidence of a recovery in its operating and financial performance. Adjusted EBITDA

AbbVie’s ABBV stock has declined 4.4% since it announced second-quarter 2026 results on July 31. AbbVie's second-quarter 2026 results were fundamentally strong, with revenues and earnings beating

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from